2019
DOI: 10.1016/j.bbr.2019.02.034
|View full text |Cite
|
Sign up to set email alerts
|

Anxiolytic and antidepressant effects of ACPA and harmaline co-treatment

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
16
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 23 publications
(17 citation statements)
references
References 41 publications
0
16
0
Order By: Relevance
“…The number of entries in the arms was measured by two observers 41 . The number of entries in the enclosed arms and the total number of entries evaluate locomotor activity 4245 .…”
Section: Methodsmentioning
confidence: 99%
“…The number of entries in the arms was measured by two observers 41 . The number of entries in the enclosed arms and the total number of entries evaluate locomotor activity 4245 .…”
Section: Methodsmentioning
confidence: 99%
“…The percentage of time spent in the OA [% time in OA = (time spent in the OA /time spent in all arms) × 100)] and the percentage of entries into the OA [% entries in OA = (OA entries/total entries in all arms) × 100] were measured to evaluate anxious-like behaviour. In addition, the total number of entries (into both enclosed and open arms) was used to evaluate spontaneous locomotor activity 61 .…”
Section: Analysis Of Anxious-like Behaviour: Epm Testmentioning
confidence: 99%
“…Some scientific studies have reported volumetric modifications of parts of the brain in patients suffering from anxiety-depressive symptoms: conducted measurements through nuclear magnetic resonance (NMR) and positron emission tomography (PET) showed a reduction of the amygdala-hippocampus complexes and prefrontal cortexes of these patients as compared to the control group (Gupta et al, 2019). Following pharmacological therapy, the morphological and functional recovery of the aforementioned anatomical structures was found, and in animal models, the antidepressant therapy determined the multiplication of stem cells in the hippocampus and in the amygdala (Ebrahimi-Ghiri et al, 2019). Nevertheless, it is important to emphasize that pharmacological therapy does not completely solve anxiety-depressive symptoms (Akil et al, 2018).…”
Section: Classical Knowledge Of Anxiety-depression Asd and Ms: Braimentioning
confidence: 99%